Out of the 350 respondents interviewed, [81.1 % (284/350) (95 % C.I: 76.0 %–85.1 %)] had reportedly received cotrimoxazole prophylaxis at the health centres, [61.1 % (214/350) (55.8 %–66.3 %)] received the Basic Care Package, [19.4 % (68/350) (95 % C.I: 15.4 %–24.0 %)] received ART, [37.4 % (131/350) (95 % C.I: 32.3 %–42.7 %)] accessed CD4 cell count testing services, [25.7 % (90/350) (95 % C.I: 21.2  %–30.6 %)] were screened for TB and [2 % (7/350) (95 % C.I: 0.8 %–4.0 %)] benefited from other laboratory services like malaria tests. This evidence concerns the gene CD4 and malaria.